Charles Muthoga

Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus–associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial

Joseph N Jarvis, Tshepo Leeme, Mooketsi Molefi et al. · Clinical Infectious Diseases · 2018 · 82 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

The Nasopharyngeal Microbiota of Children With Respiratory Infections in Botswana

Matthew S. Kelly, Michael G. Surette, Marek Smieja et al. · The Pediatric Infectious Disease Journal · 2017 · 65 citations · Full text

Life Sciences, Microbiology, Pediatrics +17

Comparative analyses of clinical and environmental populations of <i><scp>C</scp>ryptococcus neoformans</i> in <scp>B</scp>otswana

Yuan Chen, Anastasia P. Litvintseva, Aubrey E. Frazzitta et al. · Molecular Ecology · 2015 · 61 citations · Full text

Life Sciences, Genetics, Microbiology +17

Evaluation of a Novel Semiquantitative Cryptococcal Antigen Lateral Flow Assay in Patients with Advanced HIV Disease

Joseph N Jarvis, Mark W. Tenforde, Kwana Lechiile et al. · Journal of Clinical Microbiology · 2020 · 30 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial

David S. Lawrence, Charles Muthoga, David B. Meya et al. · The Lancet Global Health · 2022 · 30 citations · Full text

Pharmacy, Infectious Diseases, Pharmacoeconomics +17